We are live on ! Find out more
ASP

Adams Street Partners Portfolio holdings

AUM $260M
1-Year Est. Return 30.38%
This Fund
S&P 500
This Quarter Est. Return
-0.68%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$321M
AUM Growth
+$20.8M
Cap. Flow
+$24.5M
Cap. Flow %
7.63%
Top 10 Hldgs %
99.63%
Holding
20
New
4
Increased
1
Reduced
1
Closed
7

Top Sells

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$7.34M
2
TDG icon
TransDigm Group
TDG
+$5.85M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$2.2M
4
ACLX
Arcellx
ACLX
+$1.19M
5
NU icon
Nu Holdings
NU
+$1.16M

Sector Composition

Rank Sector Weight
1 Technology 73.77%
2 Healthcare 20.44%
3 Industrials 5.79%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCTY icon
1
Paylocity
PCTY
$7.38B
$118M 36.78%
593,200
RMNI icon
2
Rimini Street
RMNI
$459M
$97.1M 30.29%
23,565,433
MLYS icon
3
Mineralys Therapeutics
MLYS
$2.35B
$37.9M 11.82%
+2,419,501
New +$40.7M
QTWO icon
4
Q2 Holdings
QTWO
$3.77B
$19.1M 5.97%
777,562
VCSA
5
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$18M 5.62%
938,225
ICVX
6
DELISTED
Icosavax, Inc. Common Stock
ICVX
$12.9M 4.02%
2,220,681
-254,918
-10% -$2.2M
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$11.1M 3.47%
2,947,809
CRVS icon
8
Corvus Pharmaceuticals
CRVS
$1.1B
$2.98M 0.93%
3,275,616
HCP
9
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$1.69M 0.53%
+57,855
New +$1.73M
APTX
10
DELISTED
Aptinyx Inc. Common Stock
APTX
$649K 0.2%
5,395,996
WMS icon
11
Advanced Drainage Systems
WMS
$11.1B
$546K 0.17%
+6,486
New +$571K
CFLT
12
DELISTED
Confluent
CFLT
$491K 0.15%
20,406
+10
+0% +$232
FRSH icon
13
Freshworks
FRSH
$3.11B
$158K 0.05%
+10,260
New +$155K
ACLX
14
DELISTED
Arcellx
ACLX
-38,544
Closed -$1.19M
AMPL icon
15
Amplitude
AMPL
$1.18B
-41,440
Closed -$501K
GTLB icon
16
GitLab
GTLB
$5.72B
-161,488
Closed -$7.34M
IONQ icon
17
IonQ
IONQ
$12.6B
-31,629
Closed -$109K
LZ icon
18
LegalZoom.com
LZ
$1.41B
-45,234
Closed -$350K
NU icon
19
Nu Holdings
NU
$71B
-286,145
Closed -$1.16M
TDG icon
20
TransDigm Group
TDG
$73.1B
-9,289
Closed -$5.85M

Similar funds

Adams Street Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Adams Street Partners held 20 positions worth $321M, up 6.9% from $300M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adams Street Partners deployed $24.5M of net new capital in Q1 2023, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Mineralys Therapeutics: 2,419,501 shares worth $37.9M.

By sector, the portfolio is most concentrated in Technology at 74% of assets, down from 78% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Icosavax, Inc. Common Stock, an estimated $2.2M trimmed.

  • Adams Street Partners's largest Q1 2023 buy was Mineralys Therapeutics: 2,419,501 shares worth $37.9M.
  • Adams Street Partners added most to Confluent in Q1 2023, an estimated $232 increase.
  • Adams Street Partners's biggest Q1 2023 reduction was Icosavax, Inc. Common Stock, cutting an estimated $2.2M.
  • Adams Street Partners fully exited GitLab in Q1 2023, selling an estimated $7.34M.
  • Adams Street Partners's ten largest holdings make up 100% of its $321M portfolio in Q1 2023.
  • Adams Street Partners opened 4 new positions and closed 7 in Q1 2023.
  • Adams Street Partners's portfolio value rose 6.9% quarter-over-quarter to $321M.

Based on Adams Street Partners's 13F filing for Q1 2023, filed 15 May 2023.